Wells Fargo
XGN icon

Wells Fargo’s Exagen XGN Stock Holding History

Wells Fargo’s Portfolio XGN Stock Details XGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.16K Sell
2,387
-1,790
-43% -$6.92K ﹤0.01% 6031
2025
Q4 		$25.4K Sell
4,177
-1,210
-22% -$11K ﹤0.01% 5732
2025
Q3 		$59.2K Hold
5,387
– – ﹤0.01% 5506
2025
Q2 		$37.6K Buy
5,387
+3,000
+126% +$18.2K ﹤0.01% 5603
2025
Q1 		$8.57K Hold
2,387
– – ﹤0.01% 5922
2024
Q4 		$9.79K Hold
2,387
– – ﹤0.01% 5941
2024
Q3 		$7.38K Hold
2,387
– – ﹤0.01% 5861
2024
Q2 		$4.34K Sell
2,387
-70
-3% -$119 ﹤0.01% 5897
2024
Q1 		$3.91K Buy
2,457
+1
+0% +$2 ﹤0.01% 5930
2023
Q4 		$4.89K Buy
2,456
+4
+0.2% +$7 ﹤0.01% 5960
2023
Q3 		$5.93K Sell
2,452
-7
-0.3% -$18 ﹤0.01% 5928
2023
Q2 		$7.13K Buy
2,459
+5
+0.2% +$14 ﹤0.01% 5994
2023
Q1 		$5.96K Buy
2,454
+2
+0.1% +$5 ﹤0.01% 6006
2022
Q4 		$5.88K Buy
2,452
+1,001
+69% +$2.57K ﹤0.01% 5724
2022
Q3 		$4K Buy
1,451
+1,000
+222% +$5.58K ﹤0.01% 5994
2022
Q2 		$2K Sell
451
-3,637
-89% -$21.2K ﹤0.01% 6388
2022
Q1 		$33K Sell
4,088
-3,595
-47% -$31K ﹤0.01% 5830
2021
Q4 		$90K Buy
7,683
+7,296
+1,885% +$85.5K ﹤0.01% 5698
2021
Q3 		$5K Hold
387
– – ﹤0.01% 6393
2021
Q2 		$6K Sell
387
-1,446
-79% -$22.2K ﹤0.01% 6302
2021
Q1 		$32K Sell
1,833
-5,621
-75% -$100K ﹤0.01% 6009
2020
Q4 		$98K Sell
7,454
-6,186
-45% -$87.4K ﹤0.01% 5370
2020
Q3 		$148K Sell
13,640
-588
-4% -$7.57K ﹤0.01% 5103
2020
Q2 		$177K Buy
14,228
+10,481
+280% +$142K ﹤0.01% 4973
2020
Q1 		$60K Buy
3,747
+3,478
+1,293% +$69K ﹤0.01% 5279
2019
Q4 		$7K Buy
+269
New +$4.79K ﹤0.01% 5984

Other funds holding XGN

Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $690M AUM 57.92% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NCNMGF
Nano-Cap New Millennium Growth Fund Staten Island, New York $107M AUM
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
FCM
FourWorld Capital Management New York $196M AUM 42.39% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
MBAM
Mink Brook Asset Management West Palm Beach, Florida $179M AUM 37.68% 1-Year Est. Return

Wells Fargo's XGN Position: Q1 2026 in Review

Wells Fargo reduced its Exagen (XGN) stake by 43% in Q1 2026, selling an estimated $6.92K and leaving 2,387 shares worth $7.16K. The position accounts for ﹤0.01% of the portfolio, ranked #6031.

Wells Fargo first reported a position in XGN in Q4 2019 and has held it in 26 quarters since. The position peaked at $177K in Q2 2020. 61 funds tracked by Wall St. Rank hold XGN as of Q1 2026.

  • Wells Fargo held 2,387 shares of Exagen worth $7.16K as of Q1 2026.
  • Wells Fargo sold 1,790 Exagen shares in Q1 2026, an estimated $6.92K.
  • Exagen made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #6031 holding.
  • Wells Fargo first reported a position in Exagen in Q4 2019 and has held it in 26 quarters since.
  • Wells Fargo's Exagen position peaked at $177K in Q2 2020.
  • 61 funds tracked by Wall St. Rank held Exagen as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.